Showing results (91-100 of 134) with videos related to
Sort By:
Pageof 14
JCO Precision Oncology|April 9, 2026
Bespoke Circulating Tumor DNA Testing for Diagnostic Resolution, Disease Surveillance, and Treatment Monitoring in Hepatopancreatobiliary Malignancies: A Real-World ExperienceOluseyi Abidoye, Angelo Pirozzi, Naohiro Okano, et al.Journal of Cachexia, Sarcopenia and Muscle|August 8, 2014
Ventricular assist device implantation improves skeletal muscle function, oxidative capacity, and growth hormone/insulin-like growth factor-1 axis signaling in patients with advanced heart failureTuba Khawaja, Aalap Chokshi, Ruiping Ji, et al.Medical Education Online|April 24, 2025
A mixed methods survey of research education requirements for residents in internal medicine, neurology and transitional programsMichael O'Shea, Nikita Ashcherkin, Suganya Arunachalam Karikalan, et al.ESC Heart Failure|April 29, 2017
Periodontitis and bone metabolism in patients with advanced heart failure and after heart transplantationUlrike Schulze-Späte, Iman Mizani, Kristina Rodriguez Salaverry, et al.Journal of Cardiac Failure|February 17, 2016
Analysis of Skeletal Muscle Torque Capacity and Circulating Ceramides in Patients with Advanced Heart FailureDanielle L Brunjes, Mark Dunlop, Christina Wu, et al.Journal of Geriatric Oncology|November 11, 2019
In-hospital 30-day mortality for older patients with pancreatic cancer undergoing pancreaticoduodenectomyWalid L Shaib, Katerina Zakka, Farhan N Hoodbhoy, et al.Pancreas|July 4, 2019
Induction Therapy in Localized Pancreatic CancerWalid L Shaib, Layal Sayegh, Chao Zhang, et al.Journal for Immunotherapy of Cancer|October 18, 2023
Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancerMehmet Akce, Batoul Farran, Jeffrey M Switchenko, et al.Cancer|November 21, 2018
Role of adjuvant therapy in resected stage IA subcentimeter (T1a/T1b) pancreatic cancerWalid L Shaib, Amit Surya Narayan, Jeffrey M Switchenko, et al.Cancer Immunology, Immunotherapy : CII|June 23, 2021
A multi-center, single-arm, phase Ib study of pembrolizumab (MK-3475) in combination with chemotherapy for patients with advanced colorectal cancer: HCRN GI14-186Cameron J Herting, Matthew R Farren, Yan Tong, et al.Pageof 14